STVN

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.32
Percentage change -1.29	%

Peers: DHR TMO ABT ILMN BDX MMM MTD BIO BRKR ZBH

| Held by: IBB KOMP TXUE FPXE TMED

Scroll to Statements

Index	-	P/E	49.62	EPS (ttm)	0.49	Insider Own	81.82%	Shs Outstand	272.90M	Perf Week	-3.05%
Market Cap	6.68B	Forward P/E	32.41	EPS next Y	0.76	Insider Trans	0.00%	Shs Float	49.60M	Perf Month	11.68%
Enterprise Value	7.00B	PEG	2.82	EPS next Q	0.12	Inst Own	19.32%	Short Float	4.73%	Perf Quarter	17.24%
Income	134.61M	P/S	5.53	EPS this Y	9.22%	Inst Trans	-4.05%	Short Ratio	7.07	Perf Half Y	13.28%
Sales	1.21B	P/B	4.59	EPS next Y	22.10%	ROA	5.49%	Short Interest	2.35M	Perf YTD	12.35%
Book/sh	5.33	P/C	64.35	EPS next 5Y	17.57%	ROE	9.08%	52W High	25.88 -5.41%	Perf Year	33.48%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	-7.81% 23.16%	ROIC	7.21%	52W Low	17.12 42.99%	Perf 3Y	56.22%
Dividend Est.	0.05 (0.21%)	EV/EBITDA	27.35	Sales past 3/5Y	6.18% 14.74%	Gross Margin	26.71%	Volatility	4.07% 4.90%	Perf 5Y	-
Dividend TTM	0.06 (0.25%)	EV/Sales	5.80	EPS Y/Y TTM	-11.34%	Oper. Margin	14.37%	ATR (14)	1.16	Perf 10Y	-
Dividend Ex-Date	Jun 05, 2025	Quick Ratio	1.26	Sales Y/Y TTM	2.84%	Profit Margin	11.15%	RSI (14)	54.81	Recom	1.50
Dividend Gr. 3/5Y	6.27% -	Current Ratio	1.82	EPS Q/Q	33.07%	SMA20	1.63%	Beta	0.55	Target Price	28.09
Payout	13.11%	Debt/Eq	0.28	Sales Q/Q	5.44%	SMA50	5.71%	Rel Volume	0.71	Prev Close	24.80
Employees	-	LT Debt/Eq	0.22	Earnings	May 08 BMO	SMA200	15.24%	Avg Volume	331.92K	Price	24.48
IPO	Jul 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.77% 2.67%	Trades		Volume	236,215	Change	-1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-24	Initiated	Wolfe Research	Outperform	$28
Dec-03-24	Resumed	Morgan Stanley	Equal-Weight	$23
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold	$39 → $29
Sep-26-23	Initiated	Stephens	Overweight	$33
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$34
Aug-10-21	Initiated	Wells Fargo	Overweight	$24
Aug-10-21	Initiated	Morgan Stanley	Overweight	$26
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight	$27
Aug-10-21	Initiated	Jefferies	Buy	$25
Aug-10-21	Initiated	Citigroup	Buy	$27
Aug-10-21	Initiated	BofA Securities	Buy	$26

Show Previous Ratings

Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	GBOOY vs. BAM: Which Stock Should Value Investors Buy Now? (Zacks)
11:40AM	FLEX vs. GRMN: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GLDD vs. DY: Which Stock Is the Better Value Option? (Zacks)
11:40AM	Loading…
11:40AM	DNBBY or CMWAY: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CCU or SAM: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	TTEC or MLNK: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STRT or RACE: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STNE vs. FFIV: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GO or KMB: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CRRFY or WMT: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	ASAIY vs. K: Which Stock Is the Better Value Option? (Zacks)
11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Jun-02-25 11:40AM	GRFS vs. STVN: Which Stock Is the Better Value Option? (Zacks)
01:07AM	Loading…
May-30-25 01:07AM	Stevanato Group S.p.A. (STVN): A Bull Case Theory (Insider Monkey)
May-09-25 04:03PM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire) +6.76%
03:20AM	Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-08-25 07:50AM	Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates (Zacks)
06:46AM	Stevanato: Q1 Earnings Snapshot (Associated Press Finance)
06:37AM	Stevanato Group Reports Revenue of 256.6 Million for the First Quarter of 2025 (Business Wire)
May-07-25 09:41AM	Stevanato Group SpA (STVN) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-06-25 11:40AM	SDZNY vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
08:55AM	Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-24-25 05:15PM	Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-11-25 04:30PM	Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum (Business Wire) -6.46%
Mar-07-25 02:09AM	Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
01:52AM	Q4 2024 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents)
Mar-06-25 07:45AM	Stevanato Group (STVN) Meets Q4 Earnings Estimates (Zacks) +8.60%
06:48AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:31AM	Loading…
06:31AM	Stevanato Group Reports Record Revenue of 1,104 Million for Fiscal Year 2024 (Business Wire)
Mar-05-25 07:05AM	Earnings To Watch: Stevanato Group SpA (STVN) Reports Q4 2024 Result (GuruFocus.com)
Feb-24-25 04:02PM	Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 (Business Wire)
Feb-23-25 01:35PM	Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-13-25 12:16AM	Is Stevanato Group S.p.A. (STVN) the Best Italian Stock to Buy in 2025? (Insider Monkey) -5.08%
Jan-07-25 04:30PM	Stevanato Group to Present at Upcoming Investor Conference (Business Wire)
Dec-14-24 06:45AM	Wolfe starts Stevanato with Outperform on return to growth (TipRanks)
Dec-04-24 07:55AM	Stevanato Group assumed with an Equal Weight at Morgan Stanley (TipRanks)
Nov-11-24 06:32AM	Stevanato Group to Present at Upcoming Investor Conferences (Business Wire)
Nov-06-24 02:13AM	Stevanato Group SpA (STVN) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Nov-05-24 07:45AM	Stevanato Group (STVN) Q3 Earnings Match Estimates (Zacks) +16.10%
06:43AM	Stevanato: Q3 Earnings Snapshot (Associated Press Finance)
06:31AM	Stevanato Group Reports Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-04-24 07:03AM	Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Oct-22-24 04:30PM	Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 (Business Wire)
10:01AM	Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-08-24 07:25AM	Nipro debuts D2F glass vials with Stevanatos EZ-fill tech (Packaging Gateway)
Oct-01-24 06:30AM	Stevanato Group Will Introduce Its Large-Volume Vertiva 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan (Business Wire)
Sep-30-24 11:31AM	Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors? (Insider Monkey) -6.24%
Sep-27-24 10:48AM	Heres Why ClearBridge SMID Cap Growth Strategy Exited Stevanato (STVN) (Insider Monkey)
Sep-26-24 07:04AM	Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry "Alliance for RTU" (Business Wire)
Sep-12-24 08:54AM	Heres What Weighed on Stevanato Group S.p.A.s (STVN) Results (Insider Monkey)
Sep-11-24 04:28AM	Should You Hold Stevanato Group S.p.A. (STVN)? (Insider Monkey)
Aug-29-24 04:30PM	Stevanato Group to Present at Upcoming Investor Conferences (Business Wire) +6.52%
Aug-23-24 06:54AM	Multiple Factors Pulled Down Stevanato Group S.p.A. (STVN) Shares in Q2 (Insider Monkey)
Aug-16-24 03:36AM	Stevanato Group SpA (STVN) Fell on Disappointing Quarter and Reduced Guidance (Insider Monkey)
Aug-07-24 08:42AM	Implied Volatility Surging for Stevanato Group (STVN) Stock Options (Zacks)
01:25AM	Q2 2024 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 07:50AM	Stevanato Group (STVN) Q2 Earnings Match Estimates (Zacks) +5.75%
06:47AM	Stevanato: Q2 Earnings Snapshot (Associated Press Finance)
06:31AM	Stevanato Group Reports Financial Results for the Second Quarter of 2024 (Business Wire)
Jul-25-24 06:30AM	Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire) -9.01%
Jul-19-24 10:00AM	Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for (Zacks)
May-30-24 05:00AM	Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill Syringes and Cartridges (Business Wire)
May-28-24 07:00AM	Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro (Business Wire)
May-24-24 04:10PM	Stevanato Group Announces Results of Annual General Meeting (Business Wire)
May-23-24 04:30PM	Stevanato Group to Present at Upcoming Investor Conferences (Business Wire)
May-13-24 07:05AM	Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating (MT Newswires)
May-12-24 09:25AM	Stevanato Group S.p.A. (NYSE:STVN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 12:44AM	Q1 2024 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents)
May-09-24 12:45PM	Update: Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22% (MT Newswires) -21.59%
10:53AM	STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:16AM	Sector Update: Health Care Stocks Steady Pre-Bell Thursday (MT Newswires)
08:52AM	Sector Update: Health Care (MT Newswires)
08:41AM	Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking (Benzinga)
07:34AM	Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut (MT Newswires)
06:46AM	Stevanato: Q1 Earnings Snapshot (Associated Press Finance)
06:39AM	Stevanato Group Reports Financial Results for the First Quarter of 2024 (Business Wire)
May-01-24 04:30PM	Stevanato Group to Present at the Bank of America Securities Healthcare Conference (Business Wire) -5.03%
Apr-25-24 04:04PM	Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
10:02AM	Stevanato Group (STVN) to Report Q1 Results: What You Should Expect (Zacks)
Apr-22-24 06:08PM	25 Richest Billionaires in Healthcare Industry (Insider Monkey)
Apr-06-24 08:37PM	11 Best Italian Stocks To Invest In 2024 (Insider Monkey)
Apr-04-24 08:00AM	Stevanato Group appoints Ugo Gay as Chief Operations Officer (Business Wire)
Apr-01-24 07:21AM	Here's Why Stevanato (STVN) Declined in Q4 (Insider Monkey)
Mar-29-24 04:51AM	Here's Why Stevanato Group S.p.A. (STVN) Shares Sold Off in Q4 (Insider Monkey)
Mar-26-24 04:10PM	Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares (Business Wire)
Mar-21-24 11:45PM	Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares (Business Wire) +9.54%
Mar-20-24 05:12PM	Stevanato Group Announces Public Offering of Ordinary Shares (Business Wire) -5.25%
Mar-12-24 07:37AM	Should You Hold Stevanato Group S.p.A. (STVN) for the Long-Term? (Insider Monkey)
Mar-11-24 05:05PM	Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum (Business Wire)
Mar-08-24 02:35PM	Stevanato Group S.p.A. (NYSE:STVN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-07-24 11:33PM	Q4 2023 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents) -8.22%
06:49AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023 (Business Wire)
Mar-05-24 08:01AM	Jim Cramer's Latest Lightning Round: 5 Stock Recommendations (Insider Monkey)
Feb-22-24 04:30PM	Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024 (Business Wire) +5.23%
Feb-17-24 06:56AM	Stevanato Group SpA (STVN) Was up 52% in 2023 Despite Q4 Weakness (Insider Monkey)
Jan-24-24 08:00AM	Stevanato Group Launches EZ-fill Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization (Business Wire)
Jan-22-24 06:43AM	Stevanato Group S.p.A. (STVN) Fell on Investor Concerns (Insider Monkey)

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stocchi Mauro	CHIEF BUSINESS OFFICER	Jun 12 '25	Proposed Sale	21.56	12,888	277,865		Jun 11 09:43 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Stevanato Group Spa

Upgrade your FINVIZ experience